Quality of health care of rosacea in germany from the patient's perspective: Results of the national health care study rosareal 2009

Dermatology

Volumn 223, Issue 2, 2011, Pages 124-130

  Langenbruch, A K ^a   Beket, E ^a   Augustin, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Health services research; Patient advocacy groups; Quality of life; Rosacea

Indexed keywords

ANTIBIOTIC AGENT; HYDROCORTISONE; ICHTHAMMOL; ISOTRETINOIN; METRONIDAZOLE; STEROID; SUNSCREEN;

ADULT; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GERMANY; HEALTH CARE QUALITY; HUMAN; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; OINTMENT; PRIORITY JOURNAL; PSORIASIS; PUBLIC HEALTH SERVICE; QUESTIONNAIRE; ROSACEA; TOPICAL TREATMENT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; CORTISONE; COSMETICS; CROSS-SECTIONAL STUDIES; DERMATITIS, ATOPIC; FEMALE; GERMANY; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PSORIASIS; QUALITY OF HEALTH CARE; QUALITY OF LIFE; QUESTIONNAIRES; ROSACEA; SEVERITY OF ILLNESS INDEX;

EID: 82455198591     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000330555     Document Type: Article

References (20)

1. Augustin M, Herberger K, Hintzen S, Heigel H, Franzke N, Schäfer I: Prevalence of skin lesions and need for treatment in a cohort of 90,880 workers. Br J Dermatol 2011 DOI: 10.1111/j.1365-2133.2011.10436.x.
2. Shuster S, Fisher GH, Harris E, Binnell D: The effect of skin disease on self image. Br J Dermatol 1978; 99: 18-19. (Pubitemid 9007019)
3. Roosta N, Black DS, Peng D, Riley LW: Skin disease and stigma in emerging adulthood: impact on healthy development. J Cutan Med Surg 2010; 14: 285-290.
4. Salamon M, Chodkiewicz J, Sysa-Jedrzejowska A, Wozniacka A: Quality of life in patients with rosacea. Przegl Lek 2008; 65: 385-389.
5. Chodkiewicz J, Salamon M, Miniszewska J, Woźniacka A: Psychosocial impact of rosacea. Przegl Lek 2007; 64: 997-1001.
6. Gupta MA, Gupta AK, Chen SJ, Johnson AM: Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey - Outpatient Department Data collected by the U.S. National Center for Health Statistics from 1995 to 2002. Br J Dermatol 2005; 153: 1176-1181. (Pubitemid 41779573)
7. Gieler U, Niemeier V, Kupfer J, Brosig B, Schill, WB: Psychosomatische Dermatologie in Deutschland: eine Umfrage an 69 Hautkliniken. Hautarzt 2001; 52: 104-110. (Pubitemid 32151087)
8. Kerscher M, Reuther T: Der Fluch der Kelten - kosmetische Aspekte bei der Rosazea; in Schöfer H (ed): Rosazea: Klinik und aktuelle Therapie. Stuttgart, Georg Thieme, 2003, pp 67-72.
9. Gauwerky K, Klövekorn W, Korting HC, Lehmann P, Meigel EM, Reinel D, Ruzicka T, Schaller M, Schöfer H, Tietze J: Rosazea: Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG) [Treatment of rosacea. German National Guideline] [Internet]. University of Düsseldorf: AWMF online; 2008 Dec [cited 15.09.2010]. Available from:http://www.uni-duesseldorf.de/AWMF/ll/ 013-065.htm#60.
10. Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216. (Pubitemid 24194579)
11. Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY: The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159: 997-1035.
12. Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emanuel EJ: Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol 2002; 47: 512-518.
13. Augustin M, Reich C, Schaefer I, Zschocke I, Rustenbach SJ: Development and validation of a new instrument for the assessment of patient-defined benefit in the treatment of acne. J Dtsch Dermatol Ges 2008; 6: 113-120. (Pubitemid 351229573)
14. Augustin M, Radtke MA, Zschocke I, Blome C, Behechtnejad J, Schäfer I, Reusche M, Mielke V, Rustenbach SJ: The patient benefit index: a novel approach in patient-defined outcome measurement for skin diseases. Arch Dermatol Res 2009; 301: 561-571.
15. Augustin M, Kruger K, Radtke MA, Schwippl I, Reich K: Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology 2008; 216: 366-372. (Pubitemid 351630108)
16. Augustin M, Reich K, Reich C, Purwins S, Rustenbach SJ, Schäfer I, Radtke M: Quality of psoriasis care in Germany-results of the national study PsoHealth 2007. J Dtsch Dermatol Ges 2008; 6: 640-645.
17. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY: Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659-664.
18. Coughlin SS: Recall bias in epidemiologic studies. J Clin Epidemiol 1990; 43: 87-91. (Pubitemid 20036970)
19. Leyden JJ, Thew M, Kligman AM: Steroid rosacea. Arch Dermatol 1974; 111: 619-622.
20. Nicholson K, Abramova L, Chren M, Yeung J, Chon SY, Chen SC: A pilot quality-of-life instrument for acne rosacea. J Am Acad Dermatol 2007; 57: 213-221. (Pubitemid 47053981)